nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclophosphamide—CYP2A6—Prednisolone—ankylosing spondylitis	0.0919	0.123	CbGbCtD
Cyclophosphamide—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0557	0.0746	CbGbCtD
Cyclophosphamide—CYP2A6—Dexamethasone—ankylosing spondylitis	0.0542	0.0726	CbGbCtD
Cyclophosphamide—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0478	0.0641	CbGbCtD
Cyclophosphamide—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0371	0.0496	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0371	0.0496	CbGbCtD
Cyclophosphamide—CYP2C19—Prednisone—ankylosing spondylitis	0.0359	0.0481	CbGbCtD
Cyclophosphamide—CYP2B6—Dexamethasone—ankylosing spondylitis	0.0353	0.0473	CbGbCtD
Cyclophosphamide—ABCB1—Betamethasone—ankylosing spondylitis	0.0311	0.0417	CbGbCtD
Cyclophosphamide—ABCB1—Prednisolone—ankylosing spondylitis	0.0307	0.0411	CbGbCtD
Cyclophosphamide—ABCB1—Prednisone—ankylosing spondylitis	0.029	0.0388	CbGbCtD
Cyclophosphamide—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0287	0.0384	CbGbCtD
Cyclophosphamide—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0278	0.0372	CbGbCtD
Cyclophosphamide—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0267	0.0358	CbGbCtD
Cyclophosphamide—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0224	0.03	CbGbCtD
Cyclophosphamide—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0217	0.0291	CbGbCtD
Cyclophosphamide—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0186	0.025	CbGbCtD
Cyclophosphamide—CYP3A4—Betamethasone—ankylosing spondylitis	0.0186	0.025	CbGbCtD
Cyclophosphamide—CYP3A4—Prednisolone—ankylosing spondylitis	0.0184	0.0246	CbGbCtD
Cyclophosphamide—ABCB1—Dexamethasone—ankylosing spondylitis	0.0181	0.0242	CbGbCtD
Cyclophosphamide—CYP3A4—Prednisone—ankylosing spondylitis	0.0174	0.0233	CbGbCtD
Cyclophosphamide—CYP2D6—Dexamethasone—ankylosing spondylitis	0.017	0.0228	CbGbCtD
Cyclophosphamide—ABCB1—Methotrexate—ankylosing spondylitis	0.0145	0.0195	CbGbCtD
Cyclophosphamide—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0108	0.0145	CbGbCtD
Cyclophosphamide—Myocardial infarction—Prednisone—ankylosing spondylitis	0.000252	0.000995	CcSEcCtD
Cyclophosphamide—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.000251	0.000991	CcSEcCtD
Cyclophosphamide—Malaise—Prednisolone—ankylosing spondylitis	0.00025	0.000985	CcSEcCtD
Cyclophosphamide—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.000249	0.000983	CcSEcCtD
Cyclophosphamide—Convulsion—Prednisolone—ankylosing spondylitis	0.00024	0.000946	CcSEcCtD
Cyclophosphamide—Hypertension—Prednisolone—ankylosing spondylitis	0.000239	0.000943	CcSEcCtD
Cyclophosphamide—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000237	0.000935	CcSEcCtD
Cyclophosphamide—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000237	0.000935	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000236	0.000932	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000236	0.000929	CcSEcCtD
Cyclophosphamide—Bradycardia—Prednisone—ankylosing spondylitis	0.000235	0.000928	CcSEcCtD
Cyclophosphamide—Alopecia—Dexamethasone—ankylosing spondylitis	0.000234	0.000925	CcSEcCtD
Cyclophosphamide—Alopecia—Betamethasone—ankylosing spondylitis	0.000234	0.000925	CcSEcCtD
Cyclophosphamide—Discomfort—Prednisolone—ankylosing spondylitis	0.000233	0.000918	CcSEcCtD
Cyclophosphamide—Haemoglobin—Prednisone—ankylosing spondylitis	0.000232	0.000916	CcSEcCtD
Cyclophosphamide—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.000231	0.000912	CcSEcCtD
Cyclophosphamide—Haemorrhage—Prednisone—ankylosing spondylitis	0.000231	0.000911	CcSEcCtD
Cyclophosphamide—Erythema—Betamethasone—ankylosing spondylitis	0.000231	0.000911	CcSEcCtD
Cyclophosphamide—Erythema—Dexamethasone—ankylosing spondylitis	0.000231	0.000911	CcSEcCtD
Cyclophosphamide—Malaise—Triamcinolone—ankylosing spondylitis	0.000229	0.000905	CcSEcCtD
Cyclophosphamide—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000229	0.000904	CcSEcCtD
Cyclophosphamide—Malaise—Methylprednisolone—ankylosing spondylitis	0.000229	0.000903	CcSEcCtD
Cyclophosphamide—Oedema—Prednisolone—ankylosing spondylitis	0.000226	0.000891	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000226	0.000891	CcSEcCtD
Cyclophosphamide—Shock—Prednisolone—ankylosing spondylitis	0.000222	0.000877	CcSEcCtD
Cyclophosphamide—Cough—Triamcinolone—ankylosing spondylitis	0.000222	0.000876	CcSEcCtD
Cyclophosphamide—Convulsion—Triamcinolone—ankylosing spondylitis	0.00022	0.00087	CcSEcCtD
Cyclophosphamide—Tachycardia—Prednisolone—ankylosing spondylitis	0.00022	0.00087	CcSEcCtD
Cyclophosphamide—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00022	0.000868	CcSEcCtD
Cyclophosphamide—Hypertension—Triamcinolone—ankylosing spondylitis	0.00022	0.000867	CcSEcCtD
Cyclophosphamide—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000219	0.000865	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000218	0.000861	CcSEcCtD
Cyclophosphamide—Myalgia—Triamcinolone—ankylosing spondylitis	0.000217	0.000855	CcSEcCtD
Cyclophosphamide—Pneumonia—Methotrexate—ankylosing spondylitis	0.000216	0.000853	CcSEcCtD
Cyclophosphamide—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000216	0.000853	CcSEcCtD
Cyclophosphamide—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000216	0.000853	CcSEcCtD
Cyclophosphamide—Flushing—Prednisone—ankylosing spondylitis	0.000214	0.000846	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000214	0.000845	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000214	0.000845	CcSEcCtD
Cyclophosphamide—Discomfort—Triamcinolone—ankylosing spondylitis	0.000214	0.000844	CcSEcCtD
Cyclophosphamide—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000214	0.000843	CcSEcCtD
Cyclophosphamide—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000213	0.000841	CcSEcCtD
Cyclophosphamide—Renal failure—Methotrexate—ankylosing spondylitis	0.000211	0.000834	CcSEcCtD
Cyclophosphamide—Stomatitis—Methotrexate—ankylosing spondylitis	0.00021	0.000827	CcSEcCtD
Cyclophosphamide—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000209	0.000825	CcSEcCtD
Cyclophosphamide—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000209	0.000824	CcSEcCtD
Cyclophosphamide—Malaise—Dexamethasone—ankylosing spondylitis	0.000208	0.000821	CcSEcCtD
Cyclophosphamide—Malaise—Betamethasone—ankylosing spondylitis	0.000208	0.000821	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000208	0.000819	CcSEcCtD
Cyclophosphamide—Oedema—Triamcinolone—ankylosing spondylitis	0.000208	0.000819	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000207	0.000818	CcSEcCtD
Cyclophosphamide—Arrhythmia—Prednisone—ankylosing spondylitis	0.000206	0.000814	CcSEcCtD
Cyclophosphamide—Infection—Triamcinolone—ankylosing spondylitis	0.000206	0.000814	CcSEcCtD
Cyclophosphamide—Sweating—Methotrexate—ankylosing spondylitis	0.000206	0.000813	CcSEcCtD
Cyclophosphamide—Infection—Methylprednisolone—ankylosing spondylitis	0.000206	0.000812	CcSEcCtD
Cyclophosphamide—Haematuria—Methotrexate—ankylosing spondylitis	0.000205	0.000809	CcSEcCtD
Cyclophosphamide—Shock—Triamcinolone—ankylosing spondylitis	0.000204	0.000806	CcSEcCtD
Cyclophosphamide—Alopecia—Prednisone—ankylosing spondylitis	0.000204	0.000805	CcSEcCtD
Cyclophosphamide—Shock—Methylprednisolone—ankylosing spondylitis	0.000204	0.000804	CcSEcCtD
Cyclophosphamide—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000203	0.0008	CcSEcCtD
Cyclophosphamide—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000203	0.0008	CcSEcCtD
Cyclophosphamide—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000202	0.000798	CcSEcCtD
Cyclophosphamide—Erythema—Prednisone—ankylosing spondylitis	0.000201	0.000793	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000201	0.000792	CcSEcCtD
Cyclophosphamide—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000201	0.000792	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.0002	0.00079	CcSEcCtD
Cyclophosphamide—Convulsion—Dexamethasone—ankylosing spondylitis	0.0002	0.000789	CcSEcCtD
Cyclophosphamide—Convulsion—Betamethasone—ankylosing spondylitis	0.0002	0.000789	CcSEcCtD
Cyclophosphamide—Hypertension—Betamethasone—ankylosing spondylitis	0.000199	0.000786	CcSEcCtD
Cyclophosphamide—Hypertension—Dexamethasone—ankylosing spondylitis	0.000199	0.000786	CcSEcCtD
Cyclophosphamide—Myalgia—Dexamethasone—ankylosing spondylitis	0.000197	0.000776	CcSEcCtD
Cyclophosphamide—Myalgia—Betamethasone—ankylosing spondylitis	0.000197	0.000776	CcSEcCtD
Cyclophosphamide—Discomfort—Dexamethasone—ankylosing spondylitis	0.000194	0.000766	CcSEcCtD
Cyclophosphamide—Discomfort—Betamethasone—ankylosing spondylitis	0.000194	0.000766	CcSEcCtD
Cyclophosphamide—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000194	0.000765	CcSEcCtD
Cyclophosphamide—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000194	0.000764	CcSEcCtD
Cyclophosphamide—Pain—Prednisolone—ankylosing spondylitis	0.000193	0.000762	CcSEcCtD
Cyclophosphamide—Hepatitis—Methotrexate—ankylosing spondylitis	0.000193	0.000762	CcSEcCtD
Cyclophosphamide—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000193	0.000762	CcSEcCtD
Cyclophosphamide—Vision blurred—Prednisone—ankylosing spondylitis	0.000189	0.000748	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000189	0.000747	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000189	0.000745	CcSEcCtD
Cyclophosphamide—Oedema—Betamethasone—ankylosing spondylitis	0.000188	0.000743	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000188	0.000743	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000188	0.000743	CcSEcCtD
Cyclophosphamide—Oedema—Dexamethasone—ankylosing spondylitis	0.000188	0.000743	CcSEcCtD
Cyclophosphamide—Infection—Dexamethasone—ankylosing spondylitis	0.000187	0.000739	CcSEcCtD
Cyclophosphamide—Infection—Betamethasone—ankylosing spondylitis	0.000187	0.000739	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000187	0.000736	CcSEcCtD
Cyclophosphamide—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000186	0.000736	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000186	0.000734	CcSEcCtD
Cyclophosphamide—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000186	0.000734	CcSEcCtD
Cyclophosphamide—Visual impairment—Methotrexate—ankylosing spondylitis	0.000186	0.000734	CcSEcCtD
Cyclophosphamide—Anaemia—Prednisone—ankylosing spondylitis	0.000186	0.000733	CcSEcCtD
Cyclophosphamide—Shock—Betamethasone—ankylosing spondylitis	0.000185	0.000731	CcSEcCtD
Cyclophosphamide—Shock—Dexamethasone—ankylosing spondylitis	0.000185	0.000731	CcSEcCtD
Cyclophosphamide—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000185	0.00073	CcSEcCtD
Cyclophosphamide—Agitation—Prednisone—ankylosing spondylitis	0.000185	0.000729	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000184	0.000728	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000184	0.000728	CcSEcCtD
Cyclophosphamide—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000184	0.000726	CcSEcCtD
Cyclophosphamide—Tachycardia—Betamethasone—ankylosing spondylitis	0.000184	0.000726	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000183	0.00072	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000182	0.000719	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000182	0.000719	CcSEcCtD
Cyclophosphamide—Malaise—Prednisone—ankylosing spondylitis	0.000181	0.000715	CcSEcCtD
Cyclophosphamide—Tinnitus—Methotrexate—ankylosing spondylitis	0.00018	0.00071	CcSEcCtD
Cyclophosphamide—Anorexia—Dexamethasone—ankylosing spondylitis	0.00018	0.000709	CcSEcCtD
Cyclophosphamide—Anorexia—Betamethasone—ankylosing spondylitis	0.00018	0.000709	CcSEcCtD
Cyclophosphamide—Urticaria—Prednisolone—ankylosing spondylitis	0.000179	0.000708	CcSEcCtD
Cyclophosphamide—Fatigue—Triamcinolone—ankylosing spondylitis	0.000179	0.000706	CcSEcCtD
Cyclophosphamide—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000179	0.000705	CcSEcCtD
Cyclophosphamide—Pain—Triamcinolone—ankylosing spondylitis	0.000178	0.000701	CcSEcCtD
Cyclophosphamide—Hypotension—Betamethasone—ankylosing spondylitis	0.000176	0.000695	CcSEcCtD
Cyclophosphamide—Hypotension—Dexamethasone—ankylosing spondylitis	0.000176	0.000695	CcSEcCtD
Cyclophosphamide—Convulsion—Prednisone—ankylosing spondylitis	0.000174	0.000687	CcSEcCtD
Cyclophosphamide—Hypertension—Prednisone—ankylosing spondylitis	0.000174	0.000685	CcSEcCtD
Cyclophosphamide—Chills—Methotrexate—ankylosing spondylitis	0.000173	0.000683	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000172	0.000677	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000172	0.000677	CcSEcCtD
Cyclophosphamide—Myalgia—Prednisone—ankylosing spondylitis	0.000171	0.000675	CcSEcCtD
Cyclophosphamide—Arthralgia—Prednisone—ankylosing spondylitis	0.000171	0.000675	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000171	0.000675	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000171	0.000674	CcSEcCtD
Cyclophosphamide—Alopecia—Methotrexate—ankylosing spondylitis	0.000171	0.000673	CcSEcCtD
Cyclophosphamide—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000169	0.000668	CcSEcCtD
Cyclophosphamide—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000169	0.000668	CcSEcCtD
Cyclophosphamide—Discomfort—Prednisone—ankylosing spondylitis	0.000169	0.000667	CcSEcCtD
Cyclophosphamide—Erythema—Methotrexate—ankylosing spondylitis	0.000168	0.000663	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000166	0.000656	CcSEcCtD
Cyclophosphamide—Urticaria—Triamcinolone—ankylosing spondylitis	0.000165	0.000651	CcSEcCtD
Cyclophosphamide—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000165	0.000649	CcSEcCtD
Cyclophosphamide—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000165	0.000649	CcSEcCtD
Cyclophosphamide—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000164	0.000648	CcSEcCtD
Cyclophosphamide—Oedema—Prednisone—ankylosing spondylitis	0.000164	0.000647	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000164	0.000647	CcSEcCtD
Cyclophosphamide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000164	0.000646	CcSEcCtD
Cyclophosphamide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000164	0.000646	CcSEcCtD
Cyclophosphamide—Infection—Prednisone—ankylosing spondylitis	0.000163	0.000643	CcSEcCtD
Cyclophosphamide—Fatigue—Dexamethasone—ankylosing spondylitis	0.000162	0.000641	CcSEcCtD
Cyclophosphamide—Fatigue—Betamethasone—ankylosing spondylitis	0.000162	0.000641	CcSEcCtD
Cyclophosphamide—Shock—Prednisone—ankylosing spondylitis	0.000161	0.000637	CcSEcCtD
Cyclophosphamide—Pain—Dexamethasone—ankylosing spondylitis	0.000161	0.000636	CcSEcCtD
Cyclophosphamide—Pain—Betamethasone—ankylosing spondylitis	0.000161	0.000636	CcSEcCtD
Cyclophosphamide—Tachycardia—Prednisone—ankylosing spondylitis	0.00016	0.000632	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000159	0.000626	CcSEcCtD
Cyclophosphamide—Vision blurred—Methotrexate—ankylosing spondylitis	0.000158	0.000625	CcSEcCtD
Cyclophosphamide—Anorexia—Prednisone—ankylosing spondylitis	0.000156	0.000617	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000156	0.000615	CcSEcCtD
Cyclophosphamide—Anaemia—Methotrexate—ankylosing spondylitis	0.000155	0.000613	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000155	0.000613	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000155	0.000613	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000153	0.000604	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000153	0.000602	CcSEcCtD
Cyclophosphamide—Malaise—Methotrexate—ankylosing spondylitis	0.000152	0.000598	CcSEcCtD
Cyclophosphamide—Leukopenia—Methotrexate—ankylosing spondylitis	0.00015	0.000593	CcSEcCtD
Cyclophosphamide—Urticaria—Betamethasone—ankylosing spondylitis	0.00015	0.000591	CcSEcCtD
Cyclophosphamide—Urticaria—Dexamethasone—ankylosing spondylitis	0.00015	0.000591	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000149	0.00059	CcSEcCtD
Cyclophosphamide—Dizziness—Prednisolone—ankylosing spondylitis	0.000149	0.000589	CcSEcCtD
Cyclophosphamide—Asthenia—Triamcinolone—ankylosing spondylitis	0.000149	0.000588	CcSEcCtD
Cyclophosphamide—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000149	0.000588	CcSEcCtD
Cyclophosphamide—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000149	0.000588	CcSEcCtD
Cyclophosphamide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000149	0.000587	CcSEcCtD
Cyclophosphamide—Paraesthesia—Prednisone—ankylosing spondylitis	0.000147	0.000581	CcSEcCtD
Cyclophosphamide—Pruritus—Triamcinolone—ankylosing spondylitis	0.000147	0.00058	CcSEcCtD
Cyclophosphamide—Cough—Methotrexate—ankylosing spondylitis	0.000147	0.000579	CcSEcCtD
Cyclophosphamide—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000147	0.000578	CcSEcCtD
Cyclophosphamide—Convulsion—Methotrexate—ankylosing spondylitis	0.000146	0.000574	CcSEcCtD
Cyclophosphamide—Chest pain—Methotrexate—ankylosing spondylitis	0.000143	0.000564	CcSEcCtD
Cyclophosphamide—Myalgia—Methotrexate—ankylosing spondylitis	0.000143	0.000564	CcSEcCtD
Cyclophosphamide—Arthralgia—Methotrexate—ankylosing spondylitis	0.000143	0.000564	CcSEcCtD
Cyclophosphamide—Decreased appetite—Prednisone—ankylosing spondylitis	0.000143	0.000563	CcSEcCtD
Cyclophosphamide—Rash—Prednisolone—ankylosing spondylitis	0.000142	0.000562	CcSEcCtD
Cyclophosphamide—Dermatitis—Prednisolone—ankylosing spondylitis	0.000142	0.000561	CcSEcCtD
Cyclophosphamide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000142	0.000559	CcSEcCtD
Cyclophosphamide—Fatigue—Prednisone—ankylosing spondylitis	0.000141	0.000558	CcSEcCtD
Cyclophosphamide—Headache—Prednisolone—ankylosing spondylitis	0.000141	0.000558	CcSEcCtD
Cyclophosphamide—Discomfort—Methotrexate—ankylosing spondylitis	0.000141	0.000558	CcSEcCtD
Cyclophosphamide—Constipation—Prednisone—ankylosing spondylitis	0.00014	0.000554	CcSEcCtD
Cyclophosphamide—Confusional state—Methotrexate—ankylosing spondylitis	0.000138	0.000546	CcSEcCtD
Cyclophosphamide—Dizziness—Triamcinolone—ankylosing spondylitis	0.000137	0.000542	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000137	0.000541	CcSEcCtD
Cyclophosphamide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000137	0.000541	CcSEcCtD
Cyclophosphamide—Infection—Methotrexate—ankylosing spondylitis	0.000136	0.000538	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000135	0.000534	CcSEcCtD
Cyclophosphamide—Asthenia—Dexamethasone—ankylosing spondylitis	0.000135	0.000533	CcSEcCtD
Cyclophosphamide—Asthenia—Betamethasone—ankylosing spondylitis	0.000135	0.000533	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000134	0.00053	CcSEcCtD
Cyclophosphamide—Nausea—Prednisolone—ankylosing spondylitis	0.000134	0.000529	CcSEcCtD
Cyclophosphamide—Pruritus—Betamethasone—ankylosing spondylitis	0.000133	0.000526	CcSEcCtD
Cyclophosphamide—Pruritus—Dexamethasone—ankylosing spondylitis	0.000133	0.000526	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000133	0.000523	CcSEcCtD
Cyclophosphamide—Vomiting—Triamcinolone—ankylosing spondylitis	0.000132	0.000521	CcSEcCtD
Cyclophosphamide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000132	0.00052	CcSEcCtD
Cyclophosphamide—Rash—Triamcinolone—ankylosing spondylitis	0.000131	0.000517	CcSEcCtD
Cyclophosphamide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000131	0.000516	CcSEcCtD
Cyclophosphamide—Anorexia—Methotrexate—ankylosing spondylitis	0.000131	0.000516	CcSEcCtD
Cyclophosphamide—Rash—Methylprednisolone—ankylosing spondylitis	0.000131	0.000515	CcSEcCtD
Cyclophosphamide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000131	0.000515	CcSEcCtD
Cyclophosphamide—Urticaria—Prednisone—ankylosing spondylitis	0.00013	0.000514	CcSEcCtD
Cyclophosphamide—Headache—Triamcinolone—ankylosing spondylitis	0.00013	0.000513	CcSEcCtD
Cyclophosphamide—Headache—Methylprednisolone—ankylosing spondylitis	0.00013	0.000512	CcSEcCtD
Cyclophosphamide—Body temperature increased—Prednisone—ankylosing spondylitis	0.00013	0.000512	CcSEcCtD
Cyclophosphamide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000129	0.000509	CcSEcCtD
Cyclophosphamide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000129	0.000509	CcSEcCtD
Cyclophosphamide—Hypotension—Methotrexate—ankylosing spondylitis	0.000128	0.000506	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000125	0.000493	CcSEcCtD
Cyclophosphamide—Dizziness—Dexamethasone—ankylosing spondylitis	0.000125	0.000492	CcSEcCtD
Cyclophosphamide—Dizziness—Betamethasone—ankylosing spondylitis	0.000125	0.000492	CcSEcCtD
Cyclophosphamide—Nausea—Triamcinolone—ankylosing spondylitis	0.000123	0.000487	CcSEcCtD
Cyclophosphamide—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000123	0.000486	CcSEcCtD
Cyclophosphamide—Nausea—Methylprednisolone—ankylosing spondylitis	0.000123	0.000486	CcSEcCtD
Cyclophosphamide—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000122	0.000482	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000121	0.000477	CcSEcCtD
Cyclophosphamide—Vomiting—Dexamethasone—ankylosing spondylitis	0.00012	0.000473	CcSEcCtD
Cyclophosphamide—Vomiting—Betamethasone—ankylosing spondylitis	0.00012	0.000473	CcSEcCtD
Cyclophosphamide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000119	0.00047	CcSEcCtD
Cyclophosphamide—Rash—Dexamethasone—ankylosing spondylitis	0.000119	0.000469	CcSEcCtD
Cyclophosphamide—Rash—Betamethasone—ankylosing spondylitis	0.000119	0.000469	CcSEcCtD
Cyclophosphamide—Dermatitis—Betamethasone—ankylosing spondylitis	0.000119	0.000468	CcSEcCtD
Cyclophosphamide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000119	0.000468	CcSEcCtD
Cyclophosphamide—Fatigue—Methotrexate—ankylosing spondylitis	0.000118	0.000467	CcSEcCtD
Cyclophosphamide—Headache—Dexamethasone—ankylosing spondylitis	0.000118	0.000466	CcSEcCtD
Cyclophosphamide—Headache—Betamethasone—ankylosing spondylitis	0.000118	0.000466	CcSEcCtD
Cyclophosphamide—Asthenia—Prednisone—ankylosing spondylitis	0.000118	0.000465	CcSEcCtD
Cyclophosphamide—Pain—Methotrexate—ankylosing spondylitis	0.000117	0.000463	CcSEcCtD
Cyclophosphamide—Pruritus—Prednisone—ankylosing spondylitis	0.000116	0.000458	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000113	0.000446	CcSEcCtD
Cyclophosphamide—Diarrhoea—Prednisone—ankylosing spondylitis	0.000112	0.000443	CcSEcCtD
Cyclophosphamide—Nausea—Betamethasone—ankylosing spondylitis	0.000112	0.000442	CcSEcCtD
Cyclophosphamide—Nausea—Dexamethasone—ankylosing spondylitis	0.000112	0.000442	CcSEcCtD
Cyclophosphamide—Urticaria—Methotrexate—ankylosing spondylitis	0.000109	0.00043	CcSEcCtD
Cyclophosphamide—Dizziness—Prednisone—ankylosing spondylitis	0.000109	0.000428	CcSEcCtD
Cyclophosphamide—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000108	0.000428	CcSEcCtD
Cyclophosphamide—Vomiting—Prednisone—ankylosing spondylitis	0.000104	0.000412	CcSEcCtD
Cyclophosphamide—Rash—Prednisone—ankylosing spondylitis	0.000103	0.000408	CcSEcCtD
Cyclophosphamide—Dermatitis—Prednisone—ankylosing spondylitis	0.000103	0.000408	CcSEcCtD
Cyclophosphamide—Headache—Prednisone—ankylosing spondylitis	0.000103	0.000406	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000101	0.000399	CcSEcCtD
Cyclophosphamide—Asthenia—Methotrexate—ankylosing spondylitis	9.84e-05	0.000388	CcSEcCtD
Cyclophosphamide—Nausea—Prednisone—ankylosing spondylitis	9.75e-05	0.000385	CcSEcCtD
Cyclophosphamide—Pruritus—Methotrexate—ankylosing spondylitis	9.7e-05	0.000383	CcSEcCtD
Cyclophosphamide—Diarrhoea—Methotrexate—ankylosing spondylitis	9.38e-05	0.00037	CcSEcCtD
Cyclophosphamide—Dizziness—Methotrexate—ankylosing spondylitis	9.07e-05	0.000358	CcSEcCtD
Cyclophosphamide—Vomiting—Methotrexate—ankylosing spondylitis	8.72e-05	0.000344	CcSEcCtD
Cyclophosphamide—Rash—Methotrexate—ankylosing spondylitis	8.65e-05	0.000341	CcSEcCtD
Cyclophosphamide—Dermatitis—Methotrexate—ankylosing spondylitis	8.64e-05	0.000341	CcSEcCtD
Cyclophosphamide—Headache—Methotrexate—ankylosing spondylitis	8.59e-05	0.000339	CcSEcCtD
Cyclophosphamide—Nausea—Methotrexate—ankylosing spondylitis	8.15e-05	0.000321	CcSEcCtD
